Clinical trial
HBV Reactivation in Anti CD20 Treatment
NCT05768061 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HBV Reactivation in Anti CD20 Treatment
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 16, 2021
- Completion date
- December 31, 2023
- Enrollment
- 5,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.